These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 29710674

  • 1. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
    Chen F, Wang S, Wei Y, Wu J, Huang G, Chen J, Shi J, Xia J.
    Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [Abstract] [Full Text] [Related]

  • 3. Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6.
    Fellenberg J, Sähr H, Kunz P, Zhao Z, Liu L, Tichy D, Herr I.
    Cancer Lett; 2016 Feb 01; 371(1):134-41. PubMed ID: 26655997
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R, Hu T, Liu Y, He Y, Cao Y.
    Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 31912882
    [Abstract] [Full Text] [Related]

  • 5. Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer.
    He Q, Xue S, Tan Y, Zhang L, Shao Q, Xing L, Li Y, Xiang T, Luo X, Ren G.
    Cancer Lett; 2019 Apr 28; 448():94-104. PubMed ID: 30742942
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
    Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, Hu G, Yang Q.
    Oncogene; 2014 Jun 12; 33(24):3119-28. PubMed ID: 23851509
    [Abstract] [Full Text] [Related]

  • 7. Denosumab Induces Neoplastic Stromal Cell Apoptosis Via p62 Downregulation Dependent on Autophagy Pathway in Giant Cell Tumour of Bone.
    Chen X, Ye F, He H, Chen G, Chen Z, Ye E, He B, Yang Y, Zhang J.
    Curr Cancer Drug Targets; 2024 Jun 12; 24(5):565-578. PubMed ID: 37961860
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L, Ming Y, Zhang L, Zhou J, Xiang W, Zeng S, He H, Chen L.
    FASEB J; 2020 Apr 12; 34(4):5128-5143. PubMed ID: 32067282
    [Abstract] [Full Text] [Related]

  • 9. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
    Mei L, Sang W, Cui K, Zhang Y, Chen F, Li X.
    Cancer Sci; 2019 Feb 12; 110(2):582-595. PubMed ID: 30520540
    [Abstract] [Full Text] [Related]

  • 10. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y, Zheng H, Jiang S, Hua B.
    Oncol Rep; 2017 Aug 12; 38(2):1224-1232. PubMed ID: 28677802
    [Abstract] [Full Text] [Related]

  • 11. Expression profiles of miRNAs in giant cell tumor of bone showed miR-187-5p and miR-1323 can regulate biological functions through inhibiting FRS2.
    Jin Y, Zhang J, Zhu H, Fan G, Zhou G.
    Cancer Med; 2020 May 12; 9(9):3163-3173. PubMed ID: 32154662
    [Abstract] [Full Text] [Related]

  • 12. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
    Zhang JT, Sun W, Zhang WZ, Ge CY, Liu ZY, Zhao ZM, Lu XS, Fan YZ.
    BMC Cancer; 2014 Mar 15; 14():193. PubMed ID: 24628713
    [Abstract] [Full Text] [Related]

  • 13. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
    Zhang X, Zhang B, Zhang P, Lian L, Li L, Qiu Z, Qian K, Chen A, Liu Q, Jiang Y, Cui J, Qi B.
    PLoS One; 2019 Mar 15; 14(5):e0217181. PubMed ID: 31120927
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum miR-30d as a novel biomarker for multiple myeloma and its antitumor role in U266 cells through the targeting of the MTDH/PI3K/Akt signaling pathway.
    Zhu B, Chen H, Zhang X, Pan Y, Jing R, Shen L, Wang X, Ju S, Jin C, Cong H.
    Int J Oncol; 2018 Nov 15; 53(5):2131-2144. PubMed ID: 30132507
    [Abstract] [Full Text] [Related]

  • 16. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY, Zhang YY, Zhu BL, Feng FZ, Zhang HT, Yan H, Zhou B.
    J Ovarian Res; 2019 Jul 05; 12(1):60. PubMed ID: 31277702
    [Abstract] [Full Text] [Related]

  • 17. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway.
    Chang Y, Jia HQ, Xu B, Yang L, Xu YT, Zhang JY, Wang MQ, Yang LX, Song ZC.
    Chem Biol Drug Des; 2024 Jan 05; 103(1):e14416. PubMed ID: 38093418
    [Abstract] [Full Text] [Related]

  • 18. Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway.
    Peng C, Li Z, Niu Z, Niu W, Xu Z, Gao H, Niu W, Wang J, He Z, Gao C, Lin P, Agrez M, Zhang Z, Niu J.
    Sci Rep; 2016 Feb 05; 6():20500. PubMed ID: 26846153
    [Abstract] [Full Text] [Related]

  • 19. miR-384 targets metadherin gene to suppress growth, migration, and invasion of gastric cancer cells.
    Wang F.
    J Int Med Res; 2019 Feb 05; 47(2):926-935. PubMed ID: 30614349
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q, Liu GS, Li HP, Zhang Y, Xu XC, Gao H, Zhang W, Li T.
    Eur Rev Med Pharmacol Sci; 2019 Nov 05; 23(22):9871-9881. PubMed ID: 31799655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.